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Abstract: Missing values are a genuine issue in label-free quantitative proteomics. Recent
works have surveyed the diﬀerent statistical methods to conduct imputation and have compared
them on real or simulated datasets, and recommended a list of missing value imputation meth-
ods for proteomics application. Although insightful, these comparisons do not account for two
important facts: (i) depending on the proteomics dataset, the missingness mechanism may be of
diﬀerent natures, and (ii) each imputation method is devoted to a speciﬁc type of missingness
mechanism. As a result, we believe that the question at stake is not to ﬁnd the most accurate
imputation method in general, but instead, the most appropriate one. In this article, we de-
scribe a series of comparisons that support our views: for instance, we show that a supposedly
under-performing method (i.e. giving baseline average results), if applied at the appropriate
time in the data processing pipeline (before or after peptide aggregation) on a dataset with
the appropriate nature of missing values, can outperform a blindly applied, supposedly bet-
ter performing method (i.e. the reference method from the state-of-the-art). This leads us to
formulate few practical guidelines, regarding the choice and the application of an imputation
method in a proteomics context.
Keywords: label-free relative quantitative proteomics; missing value imputation.
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1 Introduction
The high rate of missing values in label-free quantitative proteomics is a major concern [1].
From the literature, in the case of LC-MS/MS approaches, it frequently ranges between 10 −
50%, while the proportion of peptides/proteins that exhibit at least one missing value can very
high, ranging in between 70 − 90% [2]. As a consequence, it was originally proposed to apply
imputation methods originally developed for transcriptomics and microarray data analysis [3]
to proteomics data. Then, more general methods, developed in a theoretical statistical context,
were considered [4], and adapted to some extent to proteomics datasets [5]. To date, numerous
methods exists and are available to any practitioner, either as independent packages [6, 7, 8],
or through dedicated pipeline packages such as MSnbase [9]. In addition, several methods have
been reported that successfully leverage on a multi-omics context to impute proteomics missing
values on the basis of transcriptomics observed values [10, 11, 12]. Recently, a comprehensive
survey [13] compared and discussed some well-known imputation algorithms in the context of
proteomics applications. There are numerous conclusions that can be drawn from this survey,
or from references therein.
First, there are multiple reasons why values are missing, accounting for biochemical and
analytical (miscleavage, dynamic range, ionization competition, ion suppression, etc.) to bioin-
formatics mechanisms (peptide misidentiﬁcation, ambiguous matching of the precursors in the
quantitation step, etc.). However, regardless of their origins, missing values can be cast in
three categories with regards to the statistical mechanisms that best describe them. In fact,
statisticians have deﬁned three types of missing values [4]:
• Missing Completely At Random (MCAR), which in a proteomics dataset, correspond to
the combination and propagation of multiple minor errors or stochastic ﬂuctuations (for
instance, a miss-identiﬁed peptide can or cannot be balanced by the alignment of the
precursor maps, leading to an abundance value, or on the contrary to a missing value). As
a result, each missing value cannot be directly explained by the nature of the peptide, nor
by its measured intensity [5]. As a result, MCAR aﬀect the entire dataset with a uniform
distribution.
• Missing At Random (MAR), which is a more general class than MCAR, where conditional
dependencies are accounted for. In a proteomics dataset, it is classically assumed that all
the MAR values are also MCAR, so that one is little interested in MAR [5]. However, some
MAR imputation methods can also be used for MCAR missing values, and thus applied
to proteomics datasets.
• Missing Not At Random (MNAR), which, on the contrary, have a targeted eﬀect. In mass
spectrometry-based analysis, chemical species whose abundance are close to the limit of
detection of the instrument enough record a higher rate of missing values. This is why,
MNAR-devoted imputation methods used in proteomics focus on left-censored data (that
is, the distribution of which with respect to the abundance is truncated on the left side,
i.e. on the region depicting the lower abundances).
Second, the statistics literature contains numerous imputation methods devoted to MCAR
or MAR, while very few are devoted to MNAR. The reason for this asymmetry is simple: most
of the MCAR/MAR mechanisms are generic to numerous application ﬁelds, so that it naturally
focused statisticians' eﬀorts. On the other hand, MNAR (including left-censored) mechanisms
are discipline-speciﬁc, so that a precise understanding of the mechanism underlying the data
generation is mandatory. This is why, in the comparisons depicted in [13], among the nine
methods, only three MNAR-devoted approaches were considered, among which two are based
on the same principle. Nonetheless, these nine methods have been compared on various datasets,
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that are reported to have both MNAR and MCAR, yet in unknown proportions. As a result,
even if a couple of MCAR/MAR devoted methods are shown to perform slightly better, it makes
sense to wonder if this holds in general, or if it is dataset dependent.
Even though most of the conclusions of [13] are well supported, there is a need to consider the
proportions of MCAR and MNAR as hidden variables. This idea is not new: several recent works
have proposed to perform imputation by estimating models (with maximum-likelihood [14, 15]
or with empirical Bayesian [16] methods) which are rich enough to account for both types of
missingness mechanisms. To the best of our knowledge, no study has evaluated the behaviour of
an imputation method devoted to MNAR (respectively devoted to MAR/MCAR) on a dataset
containing mainly MCAR (respectively MNAR). However, this question is of prime importance
to the practitioner, as it helps guiding the selection of an imputation algorithm according to the
risk of corrupting the downstream analysis when using an unadapted imputation method.
In this work, we have considered real and simulated datasets on which MCAR and MNAR
were introduced in controlled proportions and have compared the performances of various im-
putation methods. Numerous conclusions and recommendations can be drawn from these ex-
periments. However, beyond them, our work pinpoints the fact that most of the conclusions
regarding imputation methods cannot be claimed to hold in general. On the contrary, they
should be contextualized according to each dataset, the proportion of missing values, and their
nature.
2 Material
Simulated quantitative dataset
To generate artiﬁcial peptide abundance data, we used a simpliﬁed version of the model proposed
in [5], which reads:
yij = Pi +Gik + ij (1)
where yij is the log-transformed abundance of peptide i in the jth sample, Pi is the mean value
of peptide i, Gik is the mean diﬀerences between the condition groups, and ij is the random
error terms which stands for the peptide-wise variance. Here, Pi is randomly generated from a
Gaussian distribution with mean µ and standard deviation σ. The dynamic range of peptides
(in logarithm scale) can be therefore approximated by [µ−3σ, µ+3σ]. We considered two groups
k1 and k2 of replicates, for which Pi generation was conducted with µ = 1.5 and σ = 0.5. For
each of the two groups, we selected two disjoint subsets of peptides (20% of the total number of
peptides) and we added Gik randomly drawn from the distribution mentioned above, to simulate
a diﬀerential abundance between the peptides. Finally, the random error term has also been
simulated by random draws from a Gaussian distribution with zero mean and standard deviation
σ = 0.5. With these parameters, we simulated a log-transformed peptide abundance table with
m = 1000 peptides and n = 20 replicates (equally split into groups k1 and k2).
To derive the protein abundance data, a map describing the peptide/protein relationships
has been randomly generated by randomly drawing m integers from [1,mprot] where m is the
number of peptides and mprot < m is the number of proteins (mprot was set to m/2).
Real quantitative dataset
As a complement to the simulated data, we considered a real and publicly available dataset,
that has been collected during a study designed to compare human primary tumour-derived
xenograph proteomes of the two major histological non-small cell lung cancer subtypes, ade-
nocarcinoma (ADC) and squamous cell carcinoma (SCC), using Super-SILAC and label-free
quantiﬁcation [17]. The raw ﬁles were analyzed by MaxQuant (version 1.3.0.5). Peaks were
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searched against the UniProt human database (released July, 2012; http://www.uniprot.org)
using the Andromeda search engine included in MaxQuant. The dataset within this package
contains proteins intensity for 6 ADC and 6 SCC samples. The complete MaxQuant output
ﬁle is available on the repository of the ProteomeXchange Consortium [18], with the dataset
identiﬁer PXD000438.
As this study requires precisely controlling each missing values, one must work on a complete
dataset, i.e. where no missing value shows up. This has been obtained from the raw peptide-
level PXD000438 dataset by ﬁltering out the peptides which contain at least one missing value.
Finally, the complete peptide-level matrix was log-transformed and median normalized.
MCAR and MNAR incorporation
Let α and β be the rate of missing values and the MNAR ratio, respectively. They read:
α =
100 · (#MNAR+#MCAR)
nm
β =
100 ·#MNAR
#MNAR+#MCAR
(2)
For a given combination of α and β, the missing values are incorporated in a complete dataset
as follow:
MNAR values are incorporated using a stochastic threshold, as follows: one randomly generates
a threshold matrix T from a Gaussian distribution with parameters (µt = q, σt = 0.01),
where q is the αth quantile of the abundance distribution in the complete quantitative
dataset. Then, each cell (i, j) of the complete quantitative dataset is compared to Ti,j. If
it is greater than or equal to Ti,j, the abundance is not censored. On the contrary, if it
is strictly smaller than Ti,j, a Bernoulli draw with probability of success
β·α
100
determines if
the abundance value is censored (success), or not (failure).
MCAR values are incorporated by replacing with a missing value the abundance value of
nm (100−β)α
100
randomly chosen cells in the table of the quantitative dataset.
This strategy is summarized in Figure 1. We used it for any combination of values for α ∈
[2%, 52%] and β ∈ [0%, 100%].
[Figure 1 about here.]
3 Methods
Imputation algorithms
Since an exhaustive comparison of the missing value imputation algorithms is beyond the scope of
this study, we selected a set of characteristic and widely applied methods, representing diﬀerent
families of imputation procedures, and which are conceptually diﬀerent. We considered:
• kNN (k Nearest Neighbours) [3]: for a peptide showing missing values, the method consists
in: (i) Finding k most similar peptides to the one considered (using a particular distance
measure, e.g. Euclidean distance of Pearson's correlation coeﬃcient); (ii) Imputing each
missing value by averaging the k peptide values from the same replicate where that missing
value occurred. Preliminary exploration of the range of parameter k showed that the
imputation accuracy was rather stable for any k ∈ [10, 20], and reach its maximum to 11,
so that we used this latter value.
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• SVDimpute (Imputation with Singular Value Decomposition) [3]: The quantitative dataset
is considered a matrix on which mean centering and k-rank SVD are iteratively applied
(where k ∈ [1, n/2] where n/2 is the number of replicates in a given condition group), up
to some convergence criterion. In our case, k was tuned to 1 (k = 1 and k = 2 gave the
greatest performances according to preliminary tests).
• MLE (Imputation based on Maximum Likelihood Estimation): Assuming the quantita-
tive dataset obeys some law fθ of unknown parameter θ, maximum likelihood estimation
principle is used to derive an estimator θˆ of θ, and missing values are then imputed by
random draws of fθˆ. The literature dedicated to missing value imputation based on MLE
is vast, and we recommend [19, 20] for a comprehensive survey of the topic. In this work,
we employed the implementation available in the R package norm [21].
• MinDet (Deterministic minimum imputation) [22, 23]: It simply replaces the missing
values by the minimum value, either globally observed in the dataset, or observed in each
sample. Here, we used the 10−4 quantile.
• MinProb (Probabilistic minimum imputation): It is a stochastic version of MinDet, so
as to limit the bias introduced by multiple replacements with a unique value. The impu-
tation is performed by replacing the missing values with random draws from a Gaussian
distribution centered on the value used with MinDet, and with a variance tuned to the
median of the peptide-wise estimated variances [24].
We decided to focus on these ﬁve methods, as they represent well the various types of imputation
methods: First, according to the taxonomies provided in [25, 26], kNN, MinDet and MinProb
belong to the prediction rules methods, SVDimpute belongs to the least-square-based methods,
and ﬁnally, MLE belongs to the maximum-likelihood-based methods; so that, this set of methods
covers well the taxonomies of [25, 26]. Second, according to [13], MinDet and MinProb are
single value approaches, kNN is a local similarity approach, and SVDimpute is a global similarity
approach; so that the taxonomy of [13] is also covered. Third, MinDet and MinProb are designed
to impute MNAR values, while kNN, SVDimpute and MLE are designed for MCAR (and more
generally MAR) values. Finally, MinDet is the most naive method to deal with MNAR (and often
implemented as zero value imputation), while MLE and SVDimpute are particularly eﬃcient on
MCAR, so that comparing these three methods is insightful with regard to the conclusions of [13]
on the general dominance of MCAR/MAR-devoted methods. Let us also notice that no multiple
imputation method is considered in our work, while in practice, they provide the best results
in the state-of-the-art. The reason is the following: Multiple imputation strategies amount to
a boosting strategy, i.e. the combination of several simple methods to stabilize the results.
However, their behavior, eﬃciency and adequation to the speciﬁcities of the data are directly
related to those of the simple methods they are based of. As a result, we found it clearer to focus
on the single imputation methods, so as to best describe and understand them, and to let the
practitioner generalize our conclusion to multiple imputations. Finally, this set of algorithms
has been chosen to represent a wide diversity of strategies, on which very general conclusions
can be drawn.
Accuracy measurements
In most of the experiments, the imputation step was followed by the aggregation of peptide
abundances into protein abundances (we estimated each protein abundance with the median
abundance over the protein speciﬁc peptides). However, in few speciﬁc experiments (see Sec-
tion 4), the aggregation was conducted ﬁrst (i.e. on peptide abundances that still contain missing
values), and followed by imputation at protein-level.
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In both cases, we evaluated the performances of the imputation algorithms in the same
way: we considered the diﬀerences between the protein abundances in the original complete
quantitative dataset, and in its counterpart containing missing values that have been imputed
(either at protein or peptide-level). Such diﬀerences are classically summarized by the root
mean square error (RMSE), yet many other variants exist [27]. Within our framework, we
employed a normalized version of the RMSE called the RMSE-observations standard deviation
ratio (RSR) [28], deﬁned as follows:
RSR(XC , XI) =
RMSE(XC , XI)
sd(XC)
(3)
where XC denotes the complete quantitative dataset (before incorporating missing values), while
XI denotes the quantitative dataset after the imputation of the missing values. The reported
results corresponds to an average over 30 independent repetitions of the experiment (i.e. the
random generation of missing values as well as their imputation, for a given tuning of α and β),
so as to have more stable performance records.
4 Results
MCAR-devoted vs. MNAR-devoted imputations
[Figure 2 about here.]
[Figure 3 about here.]
Figures 2 and 3 display a series of heatmaps (with a false color code, ranging from blue,
which indicates low RSR, to red, which indicates high RSR) for the simulated and real datasets,
respectively. Within each ﬁgure, there are ﬁve graphics, corresponding to an imputation method
each. Each heatmap displays the average performances (over 30 repetitions) of the imputation
algorithm over all the range of the experimental conditions (i.e. a proportion of missing values
ranging from 2 to 52%, and an MNAR ratio ranging from 0 to 100%). Several conclusions can
be drawn from these ﬁgures.
First, irrespective of the dataset, all methods perform better when there are less missing
values, and become inaccurate with increasing proportion of missing values. Although expected,
this result assesses the validity of our comparison protocol and of our simulations.
Second, two groups of algorithms can be identiﬁed, with regard to the MNAR ratio: the
ﬁrst group is made of SVDimpute, kNN and MLE, which perform better under a small MNAR
ratio, while the second group, composed of MinDet and MinProb, performs better under a larger
MNAR ratio. This clearly indicates that, depending on the nature of the majority of the missing
values, it is important to privilege either a MCAR/MAR-devoted method, such as advocated
in [13], or, on the contrary, to favour a MNAR-devoted method, even if the latter is more naive
and provide, on average, worse results.
Third, for each method, a similar behaviour is observed on both the real and the simulated
datasets. In the case of MinDet and MinProb, the similarity is almost perfect, with particular
poor performance toward high percentages of non-random missing vales (lower right corner). In
the case of the three other methods, even if the similarity between the heatmaps derived from
the real and simulated datasets is not as good, a pattern is well-conserved. In both cases, the
best performance is reached with the lowest rate of missing value and the lowest MNAR ratio
(lower left corner), while the worst performance is reached with the greatest rate of missing value
and the greatest MNAR ratio (upper right corner). In addition, isoperformance lines are roughly
parallel to an axis going from the upper left to the lower right corner. The global stability of this
pattern indicates that, even if MCAR is possibly a simplistic process to account for the diverse
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nature of missing values that are not left-censored, the postulate at the root of these experiments
is robust. Indeed, we postulated the strong inﬂuences of both (1) the rate of missing values and
of the MNAR ratio, as well as (2) the nature of the missing values to which a given imputation
method is devoted.
Finally, if one averages the performances of the various imputation methods over all the
experiments (which amounts to consider a mean color over each graphic), it appears, that overall,
MCAR/MAR-devoted methods (SVDimpute, kNN and MLE) outperforms MNAR methods
(MinDet and MinProb). From this, we conclude that in absence of any knowledge regarding
the MNAR ratio (and assuming that all the situations are equiprobable, which remains to be
proven), it makes sense to privilege the former ones, such as advocated in [13].
However this averaging must not be overstated, as it is possible to show situations where even
the worst MNAR method (MinDet) signiﬁcantly outperforms the best MCAR/MAR methods
(MLE or SVDimpute). To further demonstrate this, we applied an unpaired two sample t-
test to assess the signiﬁcance of the diﬀerence of accuracy, between the two following pairs of
imputation methods: MinDet vs. SVDimpute (for the simulated dataset), and MinDet vs. MLE
(for the real dataset). The results are reported in Figures 4. These comparisons demonstrate
that when a high proportion (70% or more) of missing values are MNAR, MNAR imputation
methods are preferred. Although such datasets are not widespread, they are not unheard of
(see for instance [29, 30]), which advocates for the development of new methodologies that can
estimate the nature of the majority of the missing values, so as to adapt the imputation method
accordingly.
[Figure 4 about here.]
Peptide-level vs. protein-level imputations
In the literature, there is no consensus on the preferred order with respect to missing values
imputation and aggregation of peptide intensities into protein intensities. This is why, both
cases were considered in [13]. We also repeated our experiments summarized in Figures 2 and 3,
in a reversed context where the aggregation is performed ﬁrst, and the imputation is conducted at
protein level. We have compared these two approaches using the methodology described above
and present the results of a signiﬁcance analysis (at a p-value threshold of 5%) in Figures 5
and 6, where blue indicates peptide imputation superiority, red indicates protein imputation
superiority, and green indicates a non-signiﬁcant result.
[Figure 5 about here.]
[Figure 6 about here.]
As illustrated by a high proportion of blue, peptide-level imputation is most of the time
more accurate. Nevertheless, a major argument for protein-level imputation is the presence of
less missing values; indeed, if several peptides are aggregated into a protein, this aggregation
does not lead to a missing value, unless all the peptide intensities are missing, so that numerous
missing values are implicitly imputed by a value which is a neutral element with respect to the
aggregation. For instance, in the case where:
• protein intensities result from the sum of the peptide intensities (such as in [31]); then,
missing peptide intensities do not contribute to the sum, so that the result is the same as
if peptide missing values were imputed by zero.
• protein intensities result from the mean of the peptide intensities (such as in [32]); then,
missing peptide intensities do not contribute to the mean, so that the result is the same
as if peptide missing values were imputed by the mean value of the peptide intensities.
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• protein intensities result from a maximum function of the peptide intensities (sum or
mean over the three most abundant peptides, maximum peptide abundance, etc., such as
in [33, 34]); then, the result is the same as if peptide missing values were imputed by zero,
or any other small intensity.
For more general protein aggregation methods, based on more sophisticated functions (such as for
instance, weighted mean), the issue is the same (even if the formula of the neutral element may be
less trivial). The above observations are schematically described in Figure 7, where protein-level
imputation is equivalent to (i) applying an implicit imputation method on some peptide-level
missing values, that is neither controlled nor evaluated; (ii) performing the aggregation itself;
(iii) explicitly imputing the few remaining missing values. As the total number of imputed
missing values (whether implicit or explicit) is the same, it is preferable to consider an explicit
and well-justiﬁed imputation for all the missing values, which amounts to impute at peptide-level
and concurs with the results of Figures 5 and 6.
[Figure 7 about here.]
However, from Figures 5 and 6, it seemingly appears that when the data contain up to about
60% of MNAR values, and if an MNAR-devoted imputation method has been chosen a priori, it
is more eﬃcient to impute at the protein-level. This observation highlights that, on MCAR data,
an implicit and sub-optimal imputation is more eﬃcient than an MNAR imputation method.
Deriving this result on the basis of the aforementioned observation (Figures 5 and 6) requires
several steps:
1. During the aggregation process, several MCAR peptides are combined with observed pep-
tide intensities (there is very little chance that, assuming MCAR data, all the peptides of
a given protein are missing), leading to protein intensities rather than missing values.
2. As opposed to 1., let us note that MNAR peptides correspond to genuine low abundance
ions, so that there are good chances that one aggregates only missing values, leading to a
missing value at the protein level.
3. As a result from 1., it appears that if one has chosen to use a MNAR-devoted method,
MCAR are either imputed by an unadapted method (at the peptide level), or implicitly
imputed by the aggregation.
4. As a result from 2., if one uses the same MNAR-devoted method, MNAR are roughly
imputed in the same way, both at peptide and at protein levels.
5. As a result from 3. and 4., one derives that the diﬀerence in the overall quality of the
imputation (between peptide level and protein level imputation with an MNAR-devoted
method) mainly relies on that of MCAR data.
6. Let us now recall the original observation: when the data contain up to about 60% of
MNAR values, and if an MNAR-devoted imputation method has been chosen a priori, it
is more eﬃcient to impute at the protein-level.
7. Then, on the basis of 5. and 6., the observed diﬀerence in the overall comparison is mainly
explained by the performances of the imputation on the 40% or less remaining MCAR
values.
8. From 6. and 7., one derives that on these MCAR values, implicit protein-level imputation
gives more accurate results.
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9. Then combining 8. and 2. leads to the aforementioned conclusion: on MCAR, an implicit
and sub-optimal imputation is more eﬃcient than a MNAR-devoted method.
As here, the implicit imputation of the aggregation is equivalent to a mean imputation
(which can be seen as a poor MCAR method), it highlights that a bad MCAR method is
more eﬃcient on MCAR data than a good MNAR method. While this conclusion may appear
trivial, it however stresses that the adequation between the nature of the missing values and the
imputation strategy is more important than the theoretical performances (i.e. regardless the
nature of missing values) of the imputation algorithm.
In addition, a last conclusion can be drawn: as the implicit imputation performed during
the aggregation mainly operates on MCAR, so that mainly MNAR remain at protein-level, our
results support the idea that the MNAR ratio is generally more important at protein-level than
at peptide-level (such as observed in [29, 30] for instance). However, this last conclusion must
be cautiously interpreted: indeed, it does not mean that if there are a lot of MNAR, it is better
to work at protein-level: to derive such a conclusion, one would need to have mainly red cells in
the upper lines of Figures 5 and 6 graphics; yet it only holds for a couple of them (Figures 6(a)
and (b)), so that no general conclusion can be drawn.
Of course, if one changes the aggregation method, the comparison between peptide-level
and protein-level imputations will lead to slightly diﬀerent results, and we do not pretend to
be exhaustive. However, even if the aggregation strategy is more elaborated than the three
aforementioned ones (sum, mean or max), the conclusions are of the same spirit: whatever the
aggregation function, it is most likely to have a neutral element that will act as the implicit
imputation value, on the basis of which most of the aforementioned conclusions are elaborated.
5 Conclusions
Let us ﬁrst summarize the conclusions of this work into four points. (1) Imputation should be
performed at the peptide-level, since aggregating peptides into proteins beforehand amounts to
performing a ﬁrst implicit and in most of the cases, sub-optimal imputation. (2) In the ab-
sence of knowledge about the nature(s) of missing values in a particular quantitative proteomics
dataset, it makes sense to rely on a MCAR/MAR imputation method. This is supported by
numerous experiments, including ours as well as those from [13], but also by theoretical argu-
ments: by deﬁnition, missing values that should be imputed by small intensities can also show
up in a MCAR context (so that they can also be imputed to some extent by MCAR-devoted
imputation methods), while, on the contrary, a method devoted to left-censored missing value
will systematically perform poorly on other types of missing values. (3) However, this conclusion
should be moderated by the observation that the superiority of MAR/MCAR-devoted methods
only holds on the average and should be contextualized, as cases arise where MNAR-devoted
methods perform better than MCAR-devoted ones. Similarly, it appears that choosing a method
adapted to the nature of the missing values is more important than choosing a method itself, re-
gardless the nature of missing values. As a consequence, before any imputation, the practitioner
should identify the main or most likely nature among the missing values in his/her quantitative
dataset, and impute accordingly. (4) Finally, while MNAR are best imputed by speciﬁc meth-
ods, other missing values are well accounted for by MAR/MCAR-devoted methods. As it is
accepted that many types of missing values coexist in most of the quantitative datasets (see for
instance [13]), hybrid strategies (based on both MNAR- and MAR/MCAR-devoted methods)
should be considered in the future.
These elements shed a new light on the directions that methodological research should follow
with regards to missing value imputation in quantitative proteomics. MNAR-devoted methods,
that are less numerous and that have been less investigated in the general ﬁeld of statistics,
remain a subject of likely improvements. Concomitantly, important room is left to develop
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diagnosis tools, that are capable of categorizing the missing values according to the mechanism
that generated them. This diagnosis can operate at diﬀerent levels: (i) at the dataset level, so
that the imputation strategy is applied conditionally to the majority nature of missing values in
the entire dataset; (ii) at the peptide-level, so that all the missing values within a same peptide
(in a given group of replicates) are assumed to be of a same nature; (iii) at the missing value
level, so as to have a most reﬁned categorization of the missing values across the dataset. Finally,
once such diagnosis tools are available, it will be possible to elaborate hybrid strategies, that
process each group of missing values according to its nature, so as to best preserve the biological
relevance of the quantitative datasets and of the biological conclusions.
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Figure 1: Schematic view upon the strategy used for the missing data generation. This strategy
allows to control both for the total proportion of missing values generated, as well as for the
proportion of missing values which are MNAR and MCAR.
14
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(d) MinDet (e) MinProb
Figure 2: RSR for the simulated quantitative dataset; imputation is performed by considering:
kNN (a), SVDimpute (b), MLE (c), MinDet (d) and MinProb (e).
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Figure 3: RSR for the real quantitative dataset; imputation is performed by considering: kNN
(a), SVDimpute (b), MLE (c), MinDet (d) and MinProb (e).
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(a) (b)
Figure 4: (a) Comparison of SVDimpute and MinDet on the simulated dataset; (b) Comparison
of MLE and MinDet on the real dataset. A red color indicate an outperformance of MinDet,
a blue color, an underperformance of MinDet, and a green color, a diﬀerence of performance
which is not signiﬁcant with a p-value threshold of 5%.
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(a) kNN (b) SVDimpute (c) MLE
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Figure 5: Comparison of peptide-level and protein-level imputations for the simulated quanti-
tative dataset; imputation is performed by considering: kNN (a), SVDimpute (b), MLE (c),
MinDet (d) and MinProb (e). Blue indicates peptide imputation superiority, red indicates pro-
tein imputation superiority, and green indicates a non-signiﬁcant result (at 5% threshold).
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Figure 6: Comparison of peptide-level and protein-level imputations for the real quantitative
dataset; imputation is performed by considering: kNN (a), SVDimpute (b), MLE (c), MinDet (d)
and MinProb (e). Blue indicates peptide imputation superiority, red indicates protein imputation
superiority, and green indicates a non-signiﬁcant result (at 5% threshold).
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Figure 7: Illustration of implicit missing value imputation during protein quantiﬁcation from
peptide intensity. Here the protein quantiﬁcation is considered to be performed by summing the
signal intensities of all peptides per protein.
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